<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04561440</url>
  </required_header>
  <id_info>
    <org_study_id>19EZZDC7</org_study_id>
    <nct_id>NCT04561440</nct_id>
  </id_info>
  <brief_title>Copy Number Variation in Prenatal Diagnosis</brief_title>
  <official_title>Copy Number Variation in Prenatal Diagnosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>YiYang Zhu</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Taizhou Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      An observed study is aim to map the CNVs distribution in human genome of Chinese prenatal&#xD;
      population.&#xD;
&#xD;
      Setting: Prenatal diagnosis center of Taizhou City, Zhejiang Province Patient: total cases of&#xD;
      pregnant women needed prenatal genetic diagnosing Methods: karyotype was performed with&#xD;
      combined of molecular and cytogenic protocol. Subgroup: molecular karyotyping performed by&#xD;
      genomic Chip (CMA) or NGS, the latter including cnv-seq and NIPT.&#xD;
&#xD;
      Main outcome: comparison of CNVs distributions in subgroups. Second outcome: comparison of&#xD;
      CNVs distributions in demographic dates.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2016</start_date>
  <completion_date type="Anticipated">December 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>comparison of CNVs distributions in subgroups</measure>
    <time_frame>2016-2020</time_frame>
    <description>subgroups including CNV-seq (by NGS) and CMA chip</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>comparison of CNVs distributions in demographic dates.</measure>
    <time_frame>2016-2020</time_frame>
    <description>demographic dates including indication of prenatal diagnosis</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">16000</enrollment>
  <condition>Copy Number Variation</condition>
  <condition>Genome</condition>
  <arm_group>
    <arm_group_label>molecular karyotyping</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>cytogenic karyotyping</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>molecular karyotyping</intervention_name>
    <description>performed by NGS or CMA chip</description>
    <arm_group_label>cytogenic karyotyping</arm_group_label>
    <arm_group_label>molecular karyotyping</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        total population need invasival prenatal diagnosis, which including total pregnant women&#xD;
        whose aged over than 35 in Taizhou City of East China.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  total population need invasival prenatal diagnosis&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  multipara&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Taizhou Hospital of Zhejiang province</name>
      <address>
        <city>Taizhou</city>
        <state>Zhejiang</state>
        <zip>317000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>YiYang Zhu, MD</last_name>
      <phone>+8613819630569</phone>
      <email>zuyy@tzhospital.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 17, 2020</study_first_submitted>
  <study_first_submitted_qc>September 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 23, 2020</study_first_posted>
  <last_update_submitted>September 17, 2020</last_update_submitted>
  <last_update_submitted_qc>September 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Taizhou Hospital</investigator_affiliation>
    <investigator_full_name>YiYang Zhu</investigator_full_name>
    <investigator_title>vice dean of prenatal dignosis</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

